Rigel Pharmaceuticals (RIGL) Net Cash Flow Growth (3y) (2013 - 2026)
Rigel Pharmaceuticals (RIGL) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -50.33% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 38.47% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Rigel Pharmaceuticals | 681.25 Mn | 534.56 Mn | 54.21 Mn | -44.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.57% |
| Dec 31, 2025 | -13.73% |
| Sep 30, 2025 | -56.44% |
| Jun 30, 2025 | 44.94% |
| Mar 31, 2025 | -57.32% |
| Dec 31, 2024 | 34.61% |
| Sep 30, 2024 | 31.76% |
| Jun 30, 2024 | -45.51% |
| Mar 31, 2024 | 11.28% |
| Dec 31, 2023 | -26.80% |
| Sep 30, 2023 | -232.24% |
| Jun 30, 2023 | 43.80% |
| Mar 31, 2023 | -11.33% |
| Dec 31, 2022 | 31.16% |
| Sep 30, 2022 | 36.06% |
| Jun 30, 2022 | 27.71% |
| Mar 31, 2022 | 77.16% |
| Dec 31, 2021 | -40.54% |
| Sep 30, 2021 | -147.44% |
| Jun 30, 2021 | 37.43% |